Second, some Brca1-deficient tumors contain CD44+/CD24-/Low cells, previously associated with human breast cancer stem cells [10,11,28], whereas others contain CD133+ cells previously associated with tumors in other organs [29]. This evidence concerns the gene BRCA1 and breast carcinoma.